[videojs_hls url=’//du7x25at22z7c.cloudfront.net/436693/index_HLSv3.m3u8′ poster=’http://www.finnewsnetwork.com.au/newssystem/2023/Int_MEL_360_230920.jpg’]
Ken Aitken – Managing Director – Metgasco (ASX:MEL) is a petroleum (oil and gas) exploration and production company, listed on the Australian Securities Exchange.
Copyright 2023 – Finance News Network
Source: Finance News Network
11 Aug 2025 - Inside Etherstack’s multi-year partnership with the world’s largest telecom
Read More16 Oct 2023 - Damon Dorman, the Managing Director at Golden Mile Resources (ASX:G88), discusses the discovery of vermiculite in their Quicksilver Nickel project in Western Australia.
Read More01 Mar 2024 - Shaw and Partners Chief Investment Office Martin Crabb discusses the leading indicators for equity markets, financial conditions and central banks.
Read More10 Oct 2023 - Alex Hanly - CEO - Lithium Universe (ASX:LU7) objective is to construct a Lithium Project in Québec with utmost speed, and to assist Canada facilitate the transition towards cleaner energy.
Read More10 Oct 2023 - Andrew Worland - Managing Director and Chief Executive Officer - International Graphite (ASX:IG6) is building Australia’s capability in critical battery minerals and establishing a new ethical supply of battery anode graphite to support the global revolution in clean energy.
Read More25 Sep 2023 - Wally Graham of Resources Roadhouse at the New World Metals Conference, speaking with Dean Tuck, Managing Director of Dreadnought Resources (ASX:DRE).
Read More16 Jan 2025 - Off the Chain Capital's CIO Brian Estes discusses Bitcoin's ethical implications, investment metrics, and future outlook.
Read More23 Mar 2022 - James Power, the General Manager - Investor Relations and Marketing of the Rural Funds Group (ASX:RFF), presents on the company's HY22 results.
Read More07 Oct 2022 - Stealth Global Holdings Limited (ASX:SGI) Group Managing Director Michael Arnold discusses the business offering, M&A activity, clients, 2025 strategy and financial targets.
Read More25 Oct 2023 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses efficacy results for the company's glioblastoma therapy.
Read More
